Evidence map›Paper›PMID 40604164›Full record

ArticleScientific reports2025

Evaluation of the readability level of the package inserts of topical antifungal drugs.

Emre Uysal

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Emre UysalDepartment of Gynecology and Obstetrics, Yusufeli State Hospital, Yusufeli, Artvin, 08800, Turkey. emreuysal53@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fungi can cause infections in a number of body parts, including the skin, nails, hair and vulva-vaginal tissues. Topical antifungal drugs are the ones most frequently used to treat these infections. The purpose of this study is to assess topical antifungal medicine package insert readability using the Simple Measure of Gobbledygook (SMOG) and Flesch-Kincaid Grade Level (FKGL) readability formulas. The package inserts of 97 topical antifungal medications from the drugs.com website was examined for this investigation. The SMOG and FKGL formulae were used to assess readability. The analysis determined that the Flesch Reading Ease Score was 60.76 ± 6.08, and the total average Flesch-Kincaid Grade Level for the entire prospectus was 7.59 ± 0.91. 11.45 ± 1.09 was the mean SMOG score. The package inserts for the miconazole group showed somewhat lower FKGL and higher Flesch Reading Ease ratings. This suggests that this group is more readable than the others. The majority of the prospectuses could be read by students in the seventh grade. Additionally, variations across various drug formulations were discovered. The most readable forms were cream and gel. Topical antifungal medication leaflets have a generally moderate literacy level, suitable for students in the seventh grade. To improve patient comprehension, some sections-especially those on possible adverse effects-might need to be further clarified. Making package inserts more readable could help improve patient outcomes by encouraging adherence to treatment plans.

Indexed as

Antifungal AgentsComprehensionDrug LabelingHealth LiteracyAdministration, TopicalHumansAntifungal AgentsFlesch-KincaidPackage insertsReadabilitySMOGTopical antifungal drugs

Identifiers

PMID40604164
PMCPMC12222513

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.